Randomised Phase II Trial of Olaparib, Chemotherapy or Olaparib and Cediranib in Patients with Platinum-Resistant Ovarian Cancer (OCTOVA): a Study Protocol.
BMJ Open（2021）
Key words
oncology,chemotherapy,clinical trials,toxicity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined